SPRY:NASDAQ, ARS Pharmaceuticals, Inc.

Why SPRY stock fell on November 20

ARS Pharmaceuticals, Inc. fell 11.9% on Friday, November 20, 2026, on 2,784,259 shares. The headline around the move:

SPRY stock overview

ARS Pharmaceuticals, Inc. (SPRY:NASDAQ) closed at $2.96 on November 20, 2026, down 11.90% on the day. The stock trades 77.5% below its 52-week high of $13.15 and 21.3% above its 52-week low of $2.44. Over the past year, it lost 63.1%. ARS Pharmaceuticals, Inc. is part of the Health Care sector.

Key figures

Price
$2.96
Day change
-11.90%
Volume
2,784,259
Average volume
1,807,035
Market cap
297M+
52-week range
$2.44 – $13.15
50-day average
$3.94
200-day average
$6.90

Price action over the past year

In 252 trading sessions since November 20, 2025, SPRY closed higher on 109 days (43%). Its best day was January 9, 2026 (+19.27%) and its worst was June 25, 2026 (-23.91%). The stock moved 10% or more in a single session 14 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

SPRY news

About ARS Pharmaceuticals, Inc.

Silverback Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on leveraging its ImmunoTAC technology platform to develop tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases.

Similar stocks

Find more stocks like SPRY with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.